This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The All India Pharmaceutical Associations Consortium (AIPAC) launched its first programme for Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical sector on 12 December 2024. The MSME sector is integral to Indias pharmaceutical industry, supplying essential medicines at competitive prices.
He explained the difference between incidents and deviations, stating that deviations are departures from written procedures, while incidents are unplanned events, reinforcing the need for clear SOPs and proper documentation. The session concluded with an interactive Q&A, and discussions that reinforced the key takeaways for participants.
Global pharmaceuticalcompanies have played a pivotal role in transforming the healthcare sector in India. Approximately 70 per cent of global pharmaceuticalcompanies are expected to achieve annual growth of over 10 per cent in India over the next five years.
These programs provide a solid foundation in both the scientific principles and practical aspects of the pharmaceutical industry, preparing students to meet the ever-evolving demands of the field. One way universities foster this preparation is through partnerships with pharmaceuticalcompanies.
Additionally, they can provide support during FDA inspections and audits, ensuring that companies are well-prepared for these critical events. By partnering with a CDMO, companies can benefit from these resources without having to invest in their own infrastructure.
Session highlights: Chief Guest: The event began with a keynote address by Anil Matai, Director General, OPPI India. He opened the session by addressing the importance of product safety and quality, highlighting the global recognition of India’s pharmaceutical industry.
The report was released at an event held in New Delhi, supported by Quadria Capital and HealthQuad. The gathering brought together senior representatives from hospitals, pharmaceuticalcompanies, policymakers, and ESG leaders, including Fortis, Apollo, Quadria Capital, and Tata Capital Healthcare Fund.
Dr. Shah emphasised the importance of quality-driven processes and the need to simplify operational systems within pharmaceuticalcompanies to achieve seamless compliance with Revised Schedule M.
Navigating Regulatory Complexities with Gen AI Pharmaceuticalcompanies face mounting pressure from evolving regulatory landscapes, where non-compliance can lead to substantial financial and reputational losses. Traditionally, this process required extensive human intervention, prone to errors.
Omnichannel Marketing Strategies Omnichannel marketing ensures consistency across all platforms—whether it’s an email, social media post, or in-person event. By 2025, pharmaceuticalcompanies will need to adapt and innovate to remain competitive and effectively reach their target audiences.
Structuring patient assistance programs as independent non-profit foundations helps pharmaceuticalcompanies reduce regulatory and legal exposure while allowing for more holistic, patient-centered support. Lastly, PAPs that are directly managed by pharmaceuticalcompanies may also struggle with public image issues.
Optimizing ROI with Multichannel Approaches Using multiple channels—email, social media, in-person events—ensures no opportunity is missed. Healthcare marketing bridges the gap between pharmaceuticalcompanies and their audience, enhancing brand awareness and trust. How can digital marketing benefit pharmaceuticalcompanies?
In the digital-first era, social media marketing strategies are reshaping how pharmaceuticalcompanies engage with healthcare professionals, patients, and caregivers. Social media marketing strategies in this sector depend on a deep understanding of FDA guidance, adverse event reporting, and promotional labeling limits.
Disease awareness campaigns can also reach specific patient groups based on demographics and interests, helping pharmaceuticalcompanies create more personalized outreach. Paid campaigns on Twitter can be effective for event promotions, conference participation, and patient advocacy initiatives. In the U.S.,
This rapid processing not only enhances throughput, but will also allow pharmaceuticalcompanies to respond more swiftly to market demands. DMC’s innovative design incorporates an ultrathin conductive layer, typically made of gold, which enables the application of electrical fields across ionic and affinity membrane adsorbers.
Indian pharmaceuticalcompanies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). For instance, India’s role as a major supplier of COVID-19 vaccines underscored its capabilities in high-volume sterile manufacturing (4). and EU markets.
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Q&A Need a DTC platform?
Bridging the Gap Between Strategy and Practice in IDN Partnerships Partha Anbil ; Kamini Anbil June 9th 2025 Article In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceuticalcompanies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).
This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen PharmaceuticalCompanies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.
Related Content Bridging the Gap Between Strategy and Practice in IDN Partnerships Partha Anbil ; Kamini Anbil June 9th 2025 Article In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceuticalcompanies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).
In 2022, based upon a complaint filed by a pharmaceuticalcompany, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. So, the pharmaceuticalcompanies then pushed to get their 505(b)(2) drugs declared sole source,” Soefje said. “If This went into effect in January 2022.”
Brand Authority: By appearing at the top of search engine results, pharmaceuticalcompanies increase brand credibility among HCPs. Best For: Thought leadership, industry networking, and professional event promotions. Targeting Options: Job title, seniority, skills, company size, and industry.
full transcript below In Part 4 of our multi-part interview series, Jason Waite, an international trade expert at Alston & Bird, underscores the urgent need for pharmaceuticalcompanies to build cross-functional trade compliance teams in response to rising global trade tensions—particularly potential Section 232 tariffs.
Related Content Bridging the Gap Between Strategy and Practice in IDN Partnerships Partha Anbil ; Kamini Anbil June 9th 2025 Article In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceuticalcompanies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).
Large pharmaceuticalcompanies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51
Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceuticalcompany ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation.
24 Hours in the Hub Still Matters More June 16, 2025 By Chris Dowd, ConnectiveRx Commentary Article Pharmaceutical Commerce Pharmaceutical Commerce - June 2025 Volume 20 Issue 3 Doubling down on patient access and support fundamentals will win out over Washington’s next move.
Pharmaceuticalcompanies have responded with growing investment in the research and development of novel eye treatments and drug delivery systems designed to address key challenges in ocular therapy. Challener News Article Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise.
But the steady expansion of their use has slowed and, despite much trying, pharmaceuticalcompanies have largely failed to top the drugs’ successes. But the steady expansion of their use has slowed and, despite much trying, pharmaceuticalcompanies have largely failed to top the drugs’ successes.
CDMO Live is set to take place on 7-8 May 2025 at Rotterdam’s World Trade Center, bringing together key decision-makers in pharmaceutical outsourcing. The demand for outsourcing in pharmaceutical manufacturing has grown significantly, with nine out of ten biotechnology companies now depending on contract partners for production.
These tools reveal which digital assets—such as unbranded disease awareness pages or branded landing pages—contribute most to conversion events like doctor visits or prescription fills. These technologies allow for real-time bidding, predictive audience modeling, and performance-based optimizations that weren’t possible just a few years ago.
The initiative comes at a crucial time, as British pharmaceuticalcompanies are significantly increasing their investments in the United States. Outlaid via the Life Sciences Innovative Manufacturing Fund (LSMIF), the investment will aim to expand the UK’s manufacturing capabilities and supply chain security.
Medical affairs is the bridge between pharmaceuticalcompanies and healthcare providers. Theres also pharmacovigilance, where experts analyze medication safety and adverse events. He had the qualifications, but he wasnt getting the traction he needed. The problem wasnt his knowledge; it was his approach.
Just like Dr Reddy founded Reddy Labs, leaving an enduring legacy in the pharmaceutical sector, Dr Poonawallas legacy lies in transforming global healthcare through the Serum Institute of India, making life-saving vaccines affordable and accessible to millions around the world.
More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceuticalcompanies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US.
” How AI Will Revolutionize Medical Affairs Pharmaceuticalcompanies are actively leveraging artificial intelligence and its capabilities, encouraging their medical affairs teams to make AI a critical part of their workflows.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content